Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

Released in October, the Wave Alpha boasts Leatherman’s biggest-ever multi-tool scissors and a 2.89-inch reverse tanto blade ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

Pacira ($PCRX) announced an update on their ongoing clinical study. Study Overview: Pacira Pharmaceuticals is running a Phase 2 trial titled “A ...

You may have lost the weight you wanted to lose - but now you've stopped the jabs, how easy is it to keep it off?

Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

As 2025 draws to a close, a significant shift may be underway in the crypto market. A key pressure is finally easing.

A new Android banking trojan called Sturnus is shaping up to be one of the most capable threats we have seen in a while. It ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

Major stock indexes ended higher for a fourth straight session Tuesday, with the S&P 500 setting a fresh closing record, ...

Shark Tank” investor Kevin O'Leary has issued a stark warning regarding the proposed $2,000 “tariff dividend” cheques linked ...